Truist Financial Corp Acquires 9,746 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Truist Financial Corp grew its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 28.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 43,900 shares of the exchange traded fund’s stock after acquiring an additional 9,746 shares during the quarter. Truist Financial Corp owned 0.06% of SPDR S&P Biotech ETF worth $3,954,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new position in SPDR S&P Biotech ETF in the third quarter valued at about $141,284,000. Assetmark Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 72,653.0% during the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after purchasing an additional 588,489 shares in the last quarter. Sivik Global Healthcare LLC bought a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth about $29,640,000. Finally, Mirae Asset Securities USA Inc. increased its stake in shares of SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after buying an additional 300,000 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $90.11 on Tuesday. The company has a 50 day simple moving average of $91.26 and a 200 day simple moving average of $95.97. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm has a market cap of $6.87 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.